Clinical Trials Sponsored by Richard H. Lee

Total 555 results

H. Lee Moffitt Cancer Center and Research Institute
Cortice Biosciences, Inc.

Terminated

Fractionated Stereotactic Radiotherapy (FSRT) in Treatment of Brain Metastases

Brain Metastases | Brain Lesions | Generalized Malignancy, Primary

United States
H. Lee Moffitt Cancer Center and Research Institute
Saladax Biomedical, Inc.

Completed

Multicenter Study of Pharmacokinetic-Guided Docetaxel in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide

Breast Cancer | Breast Cancer Female

United States
H. Lee Moffitt Cancer Center and Research Institute
Millennium Pharmaceuticals, Inc.

Completed

Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma

Multiple Myeloma

United States
H. Lee Moffitt Cancer Center and Research Institute
Reliable Cancer Therapies

Completed

Gem-TABS in Unresectable Pancreatic Carcinoma

Pancreatic Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb

Completed

A Phase I/II Study of Dasatinib and Dacarbazine

Metastatic Melanoma

United States
H. Lee Moffitt Cancer Center and Research Institute
Kite, A Gilead Company

Recruiting

Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Acute Lymphoblastic Leukemia | B-Cell Lymphoblastic Leukemia

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Recruiting

Outreach Core Activities

Cancer Education | Spanish Language Cancer Education

United States, Puerto Rico
H. Lee Moffitt Cancer Center and Research Institute
Pancreatic Cancer Action Network

Recruiting

Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Pancreatic Cancer Patients

Pancreatic Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Recruiting

Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma

Ocular Melanoma | Uveal Melanoma

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Recruiting

Evaluating Stress Management Among Allogeneic HCT Caregivers

Stress | Burden

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Recruiting

Clinical Trials Outreach & Education

Knowledge, Attitudes, Practice

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Recruiting

Partnering With Food Bank to Provide Tobacco Treatment to Underserved Smokers

Smoking Cessation

United States
H. Lee Moffitt Cancer Center and Research Institute
Regeneron Pharmaceuticals; Sanofi-Synthelabo

Recruiting

Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma

Merkel Cell Carcinoma | Cutaneous Squamous Cell Carcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Recruiting

Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma

Merkel Cell Carcinoma | Neuroendocrine Carcinoma of the Skin | Trabecular Carcinoma of the Skin

United States
H. Lee Moffitt Cancer Center and Research Institute
National Pediatric Cancer Foundation

Recruiting

Evolutionary Therapy for Rhabdomyosarcoma

Rhabdomyosarcoma

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Active, not recruiting

Screen to Save: NCI Colorectal Cancer Outreach & Screening Initiative

Colorectal Cancer

United States
AC Camargo Cancer Center
H. Lee Moffitt Cancer Center and Research Institute

Completed

Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression (HORMONET)

Neuroendocrine Tumors | Estrogen Receptor Positive Tumor | Progesterone Receptor Positive Tumor

United States, Brazil
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Active, not recruiting

Colorectal Cancer Awareness, Research and Education and Screening - Rural Expansion, Access and Capacity for Health (CARES-REACH)

Colorectal Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
American Cancer Society, Inc.

Active, not recruiting

Effect of Prolonged Nightly Fasting on Immunotherapy Outcomes in HNSCC - Role of Gut Microbiome

Head and Neck Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

Smoking Cessation for Cervical Cancer Survivors

Smoking Cessation | Cervical Cancer | Tobacco Use

United States
H. Lee Moffitt Cancer Center and Research Institute
Novartis Pharmaceuticals; RECORDATI GROUP

Completed

Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)

Neuroendocrine Tumors | Carcinoid Tumors

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

Natural History of HPV Infection in Men: The HIM Study

Human Papillomavirus

United States
H. Lee Moffitt Cancer Center and Research Institute
American Cancer Society, Inc.

Completed

Increasing Access to Colorectal Cancer Testing (IACCT) for Blacks (IACCT)

Colorectal Cancer | Colorectal Carcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute
University of South Florida

Completed

Physical Activity for Advanced Stage Cancer Patients

Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

Smoking Relapse-Prevention Intervention for Cancer Patients

Smoking Cessation

United States
H. Lee Moffitt Cancer Center and Research Institute
Gateway for Cancer Research

Completed

Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease (Ustekinumab)

Graft vs. Host Disease

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia

Prostatic Hyperplasia

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer

Unspecified Adult Solid Tumor, Protocol Specific | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Completed

Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma

Melanoma

United States
H. Lee Moffitt Cancer Center and Research Institute
University of South Florida

Completed

Pilot Program to Personalize Care & Improve Quality of Life for Women With Ovarian Cancer

Ovarian Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

R115777 in Treating Patients With Advanced Bladder Cancer

Bladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Terminated

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

Breast Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Terminated

Arsenic Trioxide for Induction Therapy of Adult Patients With Leukemia

Leukemia

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal Cancer

Colorectal Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

Adenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells Matured

Melanoma (Skin)

United States
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Withdrawn

FOLFOX/Bevacizumab +/- MK-0646 in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Unknown

BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment

Unspecified Adult Solid Tumor, Protocol Specific
H. Lee Moffitt Cancer Center and Research Institute
Kite, A Gilead Company

Recruiting

Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCL

Large B-cell Lymphoma | Relapsed Non-Hodgkin Lymphoma

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Recruiting

Remote Resistance Exercise Powering Survivors - Gastrointestinal Oncology

Gastrointestinal Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Florida Breast Cancer Foundation

Recruiting

Study of Screening Brain MRIs in Stage IV Breast Cancer

Triple Negative Breast Cancer | HER2-positive Breast Cancer | Hormone Receptor-positive Breast Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Florida Department of Health

Recruiting

Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT

Acute Myeloid Leukemia

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Recruiting

Automated Video-Assisted Smoking Treatment for People Living With HIV

Smoking Cessation

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Recruiting

Clinical Trial of Green Tea Catechins in Men on Active Surveillance

Prostate Cancer | Prostate Adenocarcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Active, not recruiting

Phase II Study of Pembrolizumab and Lenvatinib in Advanced Well-differentiated Neuroendocrine Tumors

Neuroendocrine Tumors | Neuroendocrine Carcinoma | Neuroendocrine Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Janssen Scientific Affairs, LLC

Active, not recruiting

Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple Myeloma

Multiple Myeloma

United States
H. Lee Moffitt Cancer Center and Research Institute
Kite, A Gilead Company

Active, not recruiting

Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes

Diffuse Large B Cell Lymphoma | Transformed Lymphoma

United States
H. Lee Moffitt Cancer Center and Research Institute
AstraZeneca; Brooklyn ImmunoTherapeutics, LLC

Active, not recruiting

IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma

Squamous Cell Carcinoma of the Head and Neck | Oropharynx Squamous Cell Carcinoma | Squamous Cell Carcinoma | Oral Cavity Squamous Cell Carcinoma | Metastatic Squamous Cell Carcinoma | Hypopharynx Squamous Cell Carcinoma | Paranasal Sinus Squamous Cell Carcinoma | Larynx Squamous Cell Carcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Completed

Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma

Glioblastoma | Brain Tumor | GBM

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

Motivating a Spectrum of Cancer Patients to Quit Smoking

Smoking | Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

Extended Self-Help for Smoking Cessation

Smoking Cessation

United States

Clinical Trials Sponsored by Richard H. Lee

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations